Žaidimo vietos santrauka
| States | Namų rungtynės | Išvykos rungtynės |
|---|---|---|
| MIN | 16:00 | 38:00 |
| 2P M/A |
50%
3/6
|
41.7%
5/12
|
| 3P M/A |
0%
0/0
|
50%
1/2
|
| FT M/A |
0%
0/0
|
76.5%
13/17
|
| REB |
3
2/1
|
16
8/8
|
| AS | 0 | 1 |
| ST | 0 | 0 |
| TO | 1 | 0 |
| BS | 0 | 1 |
| PF | 1 | 6 |
| PTS | 6 | 26 |
| EFF | 5 | 32 |
| GM | 1 | 2 |
| States | Namų rungtynės | Išvykos rungtynės |
|---|---|---|
| MIN | 16:00 | 19:00 |
| 2P M/A |
50%
3/6
|
41.7%
5/12
|
| 3P M/A |
0%
0/0
|
50%
1/2
|
| FT M/A |
0%
0/0
|
76.5%
13/17
|
| REB |
3
2/1
|
8
4/4
|
| AS | 0 | 0.5 |
| ST | 0 | 0 |
| TO | 1 | 0 |
| BS | 0 | 0.5 |
| PF | 1 | 3 |
| PTS | 6 | 13 |
| EFF | 5 | 16 |
| GM | 1 | 2 |
Žaidimo rezultatų santrauka
| States | Pralaimėjimai |
|---|---|
| MIN | 54:00 |
| 2P M/A |
44.4%
8/18
|
| 3P M/A |
50%
1/2
|
| FT M/A |
76.5%
13/17
|
| REB |
19
10/9
|
| AS | 1 |
| ST | 0 |
| TO | 1 |
| BS | 1 |
| PF | 7 |
| PTS | 32 |
| EFF | 37 |
| GM | 3 |
| States | Pralaimėjimai |
|---|---|
| MIN | 18:00 |
| 2P M/A |
44.4%
8/18
|
| 3P M/A |
50%
1/2
|
| FT M/A |
76.5%
13/17
|
| REB |
6.3
3.3/3
|
| AS | 0.3 |
| ST | 0 |
| TO | 0.3 |
| BS | 0.3 |
| PF | 2.3 |
| PTS | 10.7 |
| EFF | 12.3 |
| GM | 3 |
Naujausi žaidimo rezultatai
| States | Paskutinės 5 rungtynės | Last 10 games |
|---|---|---|
| MIN | 54:00 | 54:00 |
| 2P M/A |
44.4%
8/18
|
44.4%
8/18
|
| 3P M/A |
50%
1/2
|
50%
1/2
|
| FT M/A |
76.5%
13/17
|
76.5%
13/17
|
| REB |
19
10/9
|
19
10/9
|
| AS | 1 | 1 |
| ST | 0 | 0 |
| TO | 1 | 1 |
| BS | 1 | 1 |
| PF | 7 | 7 |
| PTS | 32 | 32 |
| EFF | 37 | 37 |
| GM | 3 | 3 |
| States | Paskutinės 5 rungtynės | Last 10 games |
|---|---|---|
| MIN | 18:00 | 18:00 |
| 2P M/A |
44.4%
8/18
|
44.4%
8/18
|
| 3P M/A |
50%
1/2
|
50%
1/2
|
| FT M/A |
76.5%
13/17
|
76.5%
13/17
|
| REB |
6.3
3.3/3
|
6.3
3.3/3
|
| AS | 0.3 | 0.3 |
| ST | 0 | 0 |
| TO | 0.3 | 0.3 |
| BS | 0.3 | 0.3 |
| PF | 2.3 | 2.3 |
| PTS | 10.7 | 10.7 |
| EFF | 12.3 | 12.3 |
| GM | 3 | 3 |
Mėnesinė ir priešininkų analizė
| States | Suminiai | Rugsėjis |
|---|---|---|
| MIN | 54:00 | 54:00 |
| 2P M/A |
44.4%
8/18
|
44.4%
8/18
|
| 3P M/A |
50%
1/2
|
50%
1/2
|
| FT M/A |
76.5%
13/17
|
76.5%
13/17
|
| REB |
19
10/9
|
19
10/9
|
| AS | 1 | 1 |
| ST | 0 | 0 |
| TO | 1 | 1 |
| BS | 1 | 1 |
| PF | 7 | 7 |
| PTS | 32 | 32 |
| EFF | 37 | 37 |
| GM | 3 | 3 |
| States | Suminiai | Rugsėjis |
|---|---|---|
| MIN | 18:00 | 18:00 |
| 2P M/A |
44.4%
8/18
|
44.4%
8/18
|
| 3P M/A |
50%
1/2
|
50%
1/2
|
| FT M/A |
76.5%
13/17
|
76.5%
13/17
|
| REB |
6.3
3.3/3
|
6.3
3.3/3
|
| AS | 0.3 | 0.3 |
| ST | 0 | 0 |
| TO | 0.3 | 0.3 |
| BS | 0.3 | 0.3 |
| PF | 2.3 | 2.3 |
| PTS | 10.7 | 10.7 |
| EFF | 12.3 | 12.3 |
| GM | 3 | 3 |
| States | Suminiai | Tianjin Pioneers |
|---|---|---|
| MIN | 54:00 | 16:00 |
| 2P M/A |
44.4%
8/18
|
50%
3/6
|
| 3P M/A |
50%
1/2
|
0%
0/0
|
| FT M/A |
76.5%
13/17
|
0%
0/0
|
| REB |
19
10/9
|
3
2/1
|
| AS | 1 | 0 |
| ST | 0 | 0 |
| TO | 1 | 1 |
| BS | 1 | 0 |
| PF | 7 | 1 |
| PTS | 32 | 6 |
| EFF | 37 | 5 |
| GM | 3 | 1 |
| States | Suminiai | Tianjin Pioneers |
|---|---|---|
| MIN | 18:00 | 16:00 |
| 2P M/A |
44.4%
8/18
|
50%
3/6
|
| 3P M/A |
50%
1/2
|
0%
0/0
|
| FT M/A |
76.5%
13/17
|
0%
0/0
|
| REB |
6.3
3.3/3
|
3
2/1
|
| AS | 0.3 | 0 |
| ST | 0 | 0 |
| TO | 0.3 | 1 |
| BS | 0.3 | 0 |
| PF | 2.3 | 1 |
| PTS | 10.7 | 6 |
| EFF | 12.3 | 5 |
| GM | 3 | 1 |
| States | Suminiai | Shandong Hi-Speed |
|---|---|---|
| MIN | 54:00 | 16:00 |
| 2P M/A |
44.4%
8/18
|
33.3%
1/3
|
| 3P M/A |
50%
1/2
|
0%
0/0
|
| FT M/A |
76.5%
13/17
|
100%
8/8
|
| REB |
19
10/9
|
7
6/1
|
| AS | 1 | 0 |
| ST | 0 | 0 |
| TO | 1 | 0 |
| BS | 1 | 0 |
| PF | 7 | 2 |
| PTS | 32 | 10 |
| EFF | 37 | 15 |
| GM | 3 | 1 |
| States | Suminiai | Shandong Hi-Speed |
|---|---|---|
| MIN | 18:00 | 16:00 |
| 2P M/A |
44.4%
8/18
|
33.3%
1/3
|
| 3P M/A |
50%
1/2
|
0%
0/0
|
| FT M/A |
76.5%
13/17
|
100%
8/8
|
| REB |
6.3
3.3/3
|
7
6/1
|
| AS | 0.3 | 0 |
| ST | 0 | 0 |
| TO | 0.3 | 0 |
| BS | 0.3 | 0 |
| PF | 2.3 | 2 |
| PTS | 10.7 | 10 |
| EFF | 12.3 | 15 |
| GM | 3 | 1 |
| States | Suminiai | Qingdao Guoxin Pharmaceutical |
|---|---|---|
| MIN | 54:00 | 22:00 |
| 2P M/A |
44.4%
8/18
|
44.4%
4/9
|
| 3P M/A |
50%
1/2
|
50%
1/2
|
| FT M/A |
76.5%
13/17
|
55.6%
5/9
|
| REB |
19
10/9
|
9
2/7
|
| AS | 1 | 1 |
| ST | 0 | 0 |
| TO | 1 | 0 |
| BS | 1 | 1 |
| PF | 7 | 4 |
| PTS | 32 | 16 |
| EFF | 37 | 17 |
| GM | 3 | 1 |
| States | Suminiai | Qingdao Guoxin Pharmaceutical |
|---|---|---|
| MIN | 18:00 | 22:00 |
| 2P M/A |
44.4%
8/18
|
44.4%
4/9
|
| 3P M/A |
50%
1/2
|
50%
1/2
|
| FT M/A |
76.5%
13/17
|
55.6%
5/9
|
| REB |
6.3
3.3/3
|
9
2/7
|
| AS | 0.3 | 1 |
| ST | 0 | 0 |
| TO | 0.3 | 0 |
| BS | 0.3 | 1 |
| PF | 2.3 | 4 |
| PTS | 10.7 | 16 |
| EFF | 12.3 | 17 |
| GM | 3 | 1 |